LONDON - Another UK antibody company was swept up, as Novartis AG sealed a recommended all-cash offer worth £305.1 million (US$569 million) for NeuTec Pharma plc, paying more than twice the Manchester-based company's market capitalization. (BioWorld International) Read More
No Abstract BioWorld International CorrespondentIntercell AG entered a marketing and distribution agreement with Novartis AG under which the latter company will sell its Japanese encephalitis virus (JEV) vaccine, IC51, in the U.S., Europe, Japan, Latin America and other selected territories. Read More